Have AstraZeneca shares already begun a significant downtrend?
It's reached a record high this year and is currently the FTSE 100's second-largest companies, but independent analyst Alistair Strang worries about prospects.
30th April 2026 12:44
by Alistair Strang from Trends and Targets
AstraZeneca (LSE:AZN)'s share price isn’t looking great currently, the suggestion being weakness below 13,488p should drive reversal to an initial 12,760p with our secondary if broken, at 11,757p. In this instance, we can even suggest a third level drop target of 10,900p and perhaps a bounce.
- Invest with ii:Open a Stocks & Shares ISA | Top ISA Funds | Transfer your ISA to ii
Less likely is the prospect for recovery.
Apparently, above 14,472p should trigger share price movement to an initial 15,127p with our longer-term secondary, if broken, calculating at 11,757p.
Unfortunately, we lack any symptoms to refer to this messy level, other than to announce movement above 15,590p should be taken as a stain on the company's future price target levels.
But the visuals create quite a different opinion, hinting that a cycle to 10,900p has already begun.
Source: Trends and Targets. Past performance is not a guide to future performance.
Alistair Strang has led high-profile and "top secret" software projects since the late 1970s and won the original John Logie Baird Award for inventors and innovators. After the financial crash, he wanted to know "how it worked" with a view to mimicking existing trading formulas and predicting what was coming next. His results speak for themselves as he continually refines the methodology.
Alistair Strang is a freelance contributor and not a direct employee of Interactive Investor. All correspondence is with Alistair Strang, who for these purposes is deemed a third-party supplier. Buying, selling and investing in shares is not without risk. Market and company movement will affect your performance and you may get back less than you invest. Neither Alistair Strang or Interactive Investor will be responsible for any losses that may be incurred as a result of following a trading idea.
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.